SIRT1 and type 2 diabetes mellitus: In addition, Packer [98] indicated that it reduces the activation of SIRT1/PGC-1α/fibroblast growth factor and adenosine monophosphate-activated protein kinase and the inhibition of autophagy in type 2 diabetes, further causing mitochondrial dysfunction and oxidative stress and leading to myocardial fibrosis.